Free Trial
→ URGENT: If you own a home, please review the map below. (From Paradigm Press) (Ad)tc pixel
OTCMKTS:MKKGY

Merck KGaA Q1 2025 Earnings Results & Report

Merck KGaA logo
$32.62 -1.22 (-3.61%)
As of 03:58 PM Eastern

Merck KGaA beat analyst expectations on both earnings and revenue in its Q1 2025 results, released May 15, 2025. The company reported EPS of $0.59 versus the $0.50 consensus estimate, while revenue of $5.89 billion topped the $5.32 billion estimate by $571.25 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens

Merck KGaA EPS Results

Actual EPS
$0.59
Consensus EPS
$0.50
Beat/Miss
Beat by +$0.09
One Year Ago EPS
N/A
EPS Beat Rate
5 of last 8 quarters

Merck KGaA Revenue Results

Actual Revenue
$5.89 billion
Expected Revenue
$5.32 billion
Beat/Miss
Beat by +$571.25 million
YoY Revenue Growth
N/A

Upcoming Earnings

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026, based on past reporting schedules.

Conference Call Resources

Merck KGaA Q1 2025 Earnings FAQ

Merck KGaA (OTCMKTS:MKKGY) reported earnings of $0.59 per share for Q1 2025, beating the consensus estimate of $0.50. The report was announced on Thursday, May 15, 2025.

Merck KGaA reported revenue of $5.89 billion for Q1 2025, against a consensus estimate of $5.32 billion.

Merck KGaA's next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Merck KGaA on the company's earnings history page.

Merck KGaA Earnings Headlines

Merck KGaA puts its shareholders' patience to the test
 |  marketscreener.comM
Merck KGaA (MKKGY) lags Q3 earnings estimates
November 12 at 12:24 PM  |  msn.comhttps://www.msn.com/en-us/money/economy/merck-kgaa-mkkgy-lags-q3-earnings-estimates/ar-AA2hisEb
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
November 12 at 1:00 AM  |  Behind the Markets (Ad)
Merck KGaA raises 2026 outlook as Bio-Techne deal nears completion
November 12 at 12:24 PM  |  seekingalpha.comhttps://seekingalpha.com/news/4671547-merck-kgaa-raises-2026-outlook-bio-techne-deal
Merck KGaA Lifts Outlook Again on Life Science Strength
November 12 at 7:24 AM  |  bloomberg.comhttps://www.bloomberg.com/news/articles/2026-11-12/merck-kgaa-lifts-outlook-again-on-life-science-strength
RBC Upbeat on Lonza's CDMO Deal with Merck KGaA; Forecasts Updated
November 5, 2026  |  marketscreener.comM
See More Merck KGaA Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Merck KGaA? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Merck KGaA and other key companies, straight to your email.

About Merck KGaA

Merck KGaA (OTCMKTS:MKKGY) is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co.

The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility. Life Science supplies laboratory products, research tools and services, as well as materials and technologies used in pharmaceutical manufacturing.

Through its Electronics division, Merck provides specialty materials and solutions for the semiconductor and display industries. The company serves customers internationally, with operations and markets spanning numerous regions around the world.

View Merck KGaA Profile
Earnings Tools